Your browser doesn't support javascript.
loading
Development and validation of a product acceptability questionnaire for intranasal Q-Griffithsin COVID-19 prophylaxis (SPRAY PAL).
Cash, Elizabeth; Deitz, Kailyn; Potts, Kevin L; Nabeta, Henry W; Zahin, Maryam; Rai, Shesh N; Dryden, Gerald W; Palmer, Kenneth E.
Afiliación
  • Cash E; Department of Otolaryngology, Head and Neck Surgery and Communicative Disorders, University of Louisville School of Medicine, Louisville, Kentucky, USA liz.cash@louisville.edu.
  • Deitz K; UofL Healthcare-Brown Cancer Center, Louisville, Kentucky, USA.
  • Potts KL; University of Louisville School of Medicine, Louisville, Kentucky, USA.
  • Nabeta HW; Department of Otolaryngology, Head and Neck Surgery and Communicative Disorders, University of Louisville School of Medicine, Louisville, Kentucky, USA.
  • Zahin M; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville School of Medicine, Louisville, Kentucky, USA.
  • Rai SN; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville School of Medicine, Louisville, Kentucky, USA.
  • Dryden GW; College of Medicine Cancer Data Science Center, University of Cincinnati, Cincinnati, Ohio, USA.
  • Palmer KE; University of Cincinnati Cancer Center, Cincinnati, Ohio, USA.
BMJ Open ; 13(9): e073735, 2023 09 12.
Article en En | MEDLINE | ID: mdl-37699630

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / COVID-19 Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Humans Idioma: En Revista: BMJ Open Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / COVID-19 Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Humans Idioma: En Revista: BMJ Open Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido